Pioneering DCT ​

Lessons from the trenches of 35+ virtual clinical trials

Virtual trials became a necessity during the COVID-19 pandemic. The clinical research industry suffered mass disruption as a result (i.e., site closures & costly delays). Fortunately, ObvioHealth had been designing and conducting fully virtual and decentralized studies well the pandemic. Our presentation recaps lessons learned from 4+ years and 35+ decentralized clinical trials.

Interested in Viewing our Presentation?

Fill out the form below for access.

Preview the Webinar Below:

Virtual Trial Journey

A Seamless End-to-End Experience

ObvioHealth studies are run on our purpose-built platform by our own in-house virtual team. This allows us to work seamlessly from protocol design all the way through to analysis and reporting.

ObvioHealth's Numbers

Up to 4x

Faster Recruitment

3 mo ObvioHealth average vs 12 mo benchmark for site-based trials

88%

Retention

average retention vs. 70% benchmark for traditional trials

88%

ePro Compliance

average per study (digital questionnaires, daily ediary, etc.).

Our Client Roster

A. Vogel Logo.
Anatara logo.
Bayer logo.
Danoone Logo.
DSM logo.
entrinsic health logo.
Friesland campina logo.
General mills logo.
Janssen logo.
Lycored logo.
mithra logo.
Mizkan logo.
pfizer logo.
RedHill Biopharma Logo.
Renovia Logo.
Left Carousel Arrow icon.
Right carousel arrow icon.

Leverage Next Gen Solutions in Your Next DCT

Learn More